From Mr S. D. Worthing, MRPharmS
SIR,—I am happy to leave all judgments regarding efficacy, necessity and availability of Relenza to those who are chosen to make such decisions. However, I would ask Glaxo Wellcome how it justifies a National Health Service price of £24 and yet charges only IR£15.32 in the Republic of Ireland where Relenza is allowed under general medical services. At present currency rates this is almost half the UK price.
I await its reply with interest.
Stephen Worthing
Port St Mary, Isle of Man